baber/WOPTO huggingface dataset:
Patent PT-1221036-E (PT)
Inventor: CHRISTER ANDERSSON
IPC: F23B90/00
Filed: 2000-09-27
Abstract: A method for measuring the concentration of harmful gases in flue gases through a heat-producing plant that includes a combustion space and a device located downstream of the combustion space, the device includes tubes, through which for instance water, steam or air may pass in order to be heated by heat transfer from flue gases formed during the combustion. In a region near the tube device, at least one beam of ultraviolet light is emitted from a light emitter at one side of a flue gas duct to a light receiver located at the opposite side of the duct, which light emitter is connected to a spectrometer cooperating with a computer unit, in which spectrometer the light is divided spectrally.
Patent PT-1239873-E (PT)
Inventor: TOOMBS CHRISTOPHER FRANCIS
IPC: A61P9/00
Filed: 2000-12-15
Abstract: A method is provided for the localized intravascular administration of a fibrinolytic metalloproteinase to a human subject in amounts that are both safe and effective to lyse an occluding fibrin-containing blood clot, while also avoiding the neutralizing effects of ± 2 -macroglobulin in the circulating blood.
Patent PT-1282702-E (PT)
Title: Immunogenic polypeptides encoded by mage minigenes and uses thereof
Inventor: BOON-FALLEUR THIERRY
IPC: C12N15/861
Filed: 2001-05-07
Abstract: The invention discloses immunogenic polypeptides comprising several MAGE-specific antigen epitopes selected from different (i.e. discrete) members of the MAGE protein family, nucleic acids coding therefor, recombinant viruses and/or cells comprising said nucleic acids, and compositions thereof. Methods for eliciting or inducing MAGE-specific immune responses utilizing the aforementioned immunogenic agents are also disclosed.
Patent PT-1442055-E (PT)
Title: Aequorin as a growth marker in yeast
Inventor: FRAISSIGNES PAULINE
IPC: C12N9/02
Filed: 2002-10-17
Abstract: The present invention relates to a modified yeast cell containing aequorin as a growth marker - methods of making and methods of using such modified yeast cells.
Patent PT-1490106-E (PT)
Title: Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
Inventor: MUEHLRADT PETER
IPC: A61K39/39
Filed: 2003-04-03
Abstract: The use of lipopeptides or lipoproteins (I), designated macrophage activating lipopeptides (MALP), as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa is new. Also claimed is the use of (I) (with some specific compounds excepted) as adjuvants for non-mucosal vaccination. The use of a lipopeptide or lipoprotein of formula (I) is claimed as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa. [Image] R 1, R 27-25C alkyl, 7-25C alkenyl or 7-25C alkynyl; X : S, O or CH 2; R 3, R 4H or Me; and Y : sequence of 1-25 (preferably 12-25) amino acid residues, which is physiologically acceptable and not in itself immunogenic in the species to be treated; provided that the asterisked C atom has absolute R-configuration if X = S. An independent claim is also included for the use of (I) as adjuvant for non-mucosal vaccination, with the additional proviso that (I) is other than an S-(2,3-diacyloxypropyl)-cysteine peptide (I') of the sequence Asp-hcGly-Asn-Asn-Asp-Glu-Ser-Asn-Ile-Glu-Ser-Phe-Glu-Lys-Glu-Lys, where the amino acids in position 2 and optionally 3 at the N-terminal are optionally absent and/or 1 or 2 aminoacids may be deleted from the C-terminal. ACTIVITY : Immunostimulant. Mice were immunized intranasally on days 0, 7 and 14 with 40 mu g beta -galactosidase (as model antigen) or a mixture of 40 Microg beta -galactosidase and 1 Microg MALP-2 (Ia) as adjuvant. On day 28 serum samples were analyzed by enzyme-labeled immunosorbent assay for the beta -galactosidase-specific antibody titer. The titers, in absorption value units (OD 405 nm), were 0.25 in the absence of (Ia) and 0.30 in presence of (Ia). MECHANISM OF ACTION : None given.
Patent PT-1558616-E (PT)
Title: Meso-substituted porphyrins
Inventor: RONCUCCI GABRIO
IPC: A61P35/00
Filed: 2003-10-21
Abstract: Meso-substituted porphyrins of general formula (I) suitable for the use as photosensitizing agents, in particular in photodynamic therapy, are herein described.
Patent PT-1460186-E (PT)
IPC: E03C1/22
Filed: 2004-03-18
Abstract: The invention relates to a drain for draining a liquid, which drain comprises a container open at the top for collecting the liquid and a drain pipe connection which debouches into the open container, characterized in that the container has, at least in top view, a substantially triangular form. <??>The invention further relates to a method for placing and finishing a drain according to any of the foregoing claims in a floor which is enclosed by at least two walls adjoining each other at an angle, which method comprises the steps of:  arranging the triangular drain according to any of the foregoing claims in the floor in the corner against the two walls, wherein two sides of the triangular form run substantially parallel to the at least two walls; providing a slope in the floor, which slope runs substantially perpendicularly of the third side of the triangular form of the drain.  <IMAGE>
Patent PT-1752485-E (PT)
Title: Soft polyolefin foams with high heat resistance
Inventor: PURCELL DAVID
IPC: C08J9/00
Filed: 2005-08-08
Abstract: The present invention relates to soft, closed cell polyolefin foams showing a good combination of high temperature resistance and softness as well as a laminate and uses thereof.
Patent PT-1688072-E (PT)
Title: Device for preparing a beverage from a capsule by injecting a pressurized fluid
Inventor: YOAKIM ALFRED
IPC: A47J31/06
Filed: 2005-02-07
Abstract: The device has a capsule holder (4) configured for receiving a capsule and detachable with respect to a pressurized fluid supply unit (5). An injector provided for injecting fluid in the capsule is separable from the fluid supply unit when the holder is detached. The holder and the injector are associated with each other. The holder has a cup with a housing that is complementary to that of body of the capsule. An independent claim is also included for a drink vending machine comprises a drink preparation device.
Patent PT-1759001-E (PT)
Title: Bone delivery conjugates and method of using same to target proteins to bone
Inventor: CRINE PHILIPPE
IPC: A61K47/64
Filed: 2005-04-21
Abstract: The invention relates to a pharmaceutical composition comprising a bone delivery conjugate having the structure Z-sALP-Y-Dn-X, wherein X is absent or is an amino acid sequence of at least one amino acid; Y is absent or is an amino acid sequence of at least one amino acid; Z is absent or is an amino acid sequence of at least one amino acid; Dn is a poly aspartate, wherein n=10 to 16; and sALP is a soluble alkaline phosphatase and uses thereof.
Patent PT-2135014-E (PT)
Title: Method and device for the utilization of solar energy
Inventor: GRASSMANN WALTER
IPC: F24S23/00
Filed: 2008-04-03
Abstract: The present invention concerns an apparatus (100, 200) for and a method of using solar energy. To provide an alternative apparatus (100, 200) and an alternative method of using solar energy which structurally requires less complication and expenditure and which is favorable in provision and operation, in accordance with the invention there is proposed an apparatus (100, 200) comprising a target (50) and reflectors (10, 12, 210) for deflecting solar rays on to the target (50) and a corresponding method, wherein the reflectors (10, 12, 210) are respectively pivotable about an axis (20, 220) for tracking in accordance with the azimuth of the sun (30) in the course of a day, wherein the axis (20, 220) is a component part of an axis arrangement (70, 270) which is inclinable for tracking in accordance with the midday height of the sun (30) in the course of a year. If necessary it is possible to achieve continuous focusing of the system by simple mechanical compensating mechanisms.
Patent PT-2129255-E (PT)
Title: Jewellery item including spherical elements
Inventor: VAUCHER PASCAL-VINCENT
IPC: A44C5/10
Filed: 2008-04-22
Abstract: The invention relates to a jewelry item including several spherical or near-spherical elements (hereinafter spherical elements) in which each spherical element (1) includes at least one bore (2) and is connected to at least one adjacent spherical element (1). The assembly of two adjacent spherical elements (1) is carried out using a rod (3) inserted on either side into the corresponding bore (2) of each spherical element (1). A plurality of spherical elements (1) each include at least two bores (2), wherein the axis of each bore (2) extends radially relative to the centre of the spherical element (1). The spatial positioning of adjacent spherical elements (1) on either side of a common spherical element (1) is achieved by the angular orientation in space of the bores (2) relative to each other. The assembly of each adjacent spherical element (1) to the common spherical element (1) is achieved by inserting or screwing each rod (3) on either side into the corresponding bores (2). Each adjacent spherical element (1) can be a spherical element (1) that is common to one or more other adjacent spherical elements (1). The assembly of all spherical elements (1) gives a jewelry item having a desired shape.
Patent PT-2386576-E (PT)
Title: Tumor-specific recognition molecules
Inventor: KARSTEN UWE
IPC: C12N5/00
Filed: 2003-12-01
Abstract: Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6) given in the specification and below, are new. Recognition molecules (RM), especially antibodies (A) that bind specifically to the Core-1 (C1) antigen, comprising defined amino acids sequences (1-6): (a) AsnTyrTrpLeuGly (1); (b) AspIleTyrPro(Gly) 3TyrThrAsnTyrAsnGluLysPheLysGly (2); (c) AspIleTyrPro(Gly) 2SerTyrThrAsnTyrAsnGluLysPheLysGly (3); (d) TyrAspAlaAlaGlyProTrpPheAlaTyr (4); (e) TyrAspAlaAlaGlyProGlyPheAlaTyr (5); or (f) TyrAspAsnHisTyrPheAspTyr (6). Independent claims are also included for: (1) construct (B) consisting of (A) fused, chemically coupled or non-covalently associated with additional sequences and/or structures; (2) isolated nucleic acid (NA) containing sequences that encode at least one (A) or (B); (3) expression cassette or vector (X) comprising NA and functionally linked promoter; (4) virus or host cell that contains at least one (X); (5) organism that contains at least one host cell of (4); (6) method for preparing (A); and (7) kit containing (A) and/or (B). ACTIVITY : Cytostatic. A multibody (104; sequence of about 200 amino acids reproduced) was coupled to a chelating group then loaded with yttrium99. It was injected (dose 100 MicroCi) into the tail vein of a mouse, subcutaneously implanted with ZA-75-1 (Core-1 positive) tumor cells. A second dose was given after 3 weeks and this treatment produced a significant reduction in tumor growth (no figures given). MECHANISM OF ACTION : Neutralization of Core-1 antigen; Vaccine.
Patent PT-2263689-E (PT)
Title: Chimeric infectious dna clones of porcine circovirus and uses thereof
IPC: C12N15/34
Filed: 2002-12-11
Abstract: The present invention relates to an immunogenic polypeptide product which is obtainable by expressing infectious chimeric DNA clones of porcine circovirus (PCV). The present invention also relates to corresponding vaccines and means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2. The new chimeric infectious DNA clone is constructed from the nonpathogenic PCV1 in which the immunogenic ORF gene of the pathogenic PCV2 replaces a gene of the nonpathogenic PCV1, preferably in the same position.
Patent PT-608759-E (PT)
Inventor: GUIDO MELZER DR
IPC: C07D295/192
Filed: 1994-01-19
Abstract: Novel piperazine derivatives of the formula I  Y-(CmH2m-CHR<1>)n-CO-(NH-CHR<2>-CO)r-Z in which R<1>, R<2>, Y, Z, m, n and r have the meanings indicated in Patent Claim 1, inhibit the binding of fibrinogen to the fibrinogen receptor and can be used for the treatment of thromboses, apoplexy, cardiac infarct, inflammations, arteriosclerosis and tumours.
Patent PT-728859-E (PT)
Inventor: DINGER ROLF
IPC: D03D27/00
Filed: 1996-02-09
Abstract: The characteristic features in a lopped material comprising a stitched or woven backing with bonded-in loop-forming yarns are that: (i) the backing contains a multi-filament hybrid yarn of 2 types of filament (A) and (B), together with 0-40 wt.% accompanying filaments (C) where (A) is texturised and of m.pt. above 180 (esp. above 250) degrees C and (B) is of m.pt. below 220 (esp. below 180) degrees C such that the m.pt. of (B) is at least 20 (esp., at least 80) degrees C below that of (A), (ii) the wt. ratio (A):(B) is 20:80-80:20 esp. 40:60-60:40 and (iii) the loop length of the bonded-in yarns is 1-4 mm. and these yarns are multi-filament yarns of total titre 30-200 dtex and single titre 5-25 dtex and/or mono-filaments of 20-70 dtex. Pref. filaments (A) have 3-50 (esp. 8-30)% self-crimp and m.pt. 240-280 degrees C, while (B) have m.pt. 150-200 degrees C. The hybrid yarns in the base have a total titre of 80-500 (esp. 160-230) dtex, with (A) having individual titre 0.5-15 (esp. 2-10) dtex and (B) 1-20 (esp. 3-15) dtex. The backing and bonded-in yarns are pref. of the same polymer class, esp. both polyesters and the bonded-in, loop-forming yarns have m.pt. at least 20 (esp. at least 80) degrees C above the m.pt. of backing hybrid yarn component (B)
Patent PT-866691-E (PT)
Inventor: DISANTO ANTHONY R
IPC: A01N33/02
Filed: 1996-11-05
Abstract: The present invention is directed to improved methods for treating certain selegiline-responsive diseases or conditions and, more specifically, to methods in which selegiline is administered buccally or sublingually. Selegiline may be used ether as a free base or as a pharmaceutically acceptable acid addition salt. The selegiline-responsive diseases or conditions include neuronal-degenerative diseases and conditions, such as Alzheimer's disease and neuronal damage from hypoxia, stroke, ischemia, and trauma, and dopaminergic-related, selegiline responsive diseases and conditions such as depression and ADHD.
Patent PT-863776-E (PT)
Inventor: ABATANGELO GIOVANNI
IPC: A61K35/12
Filed: 1996-11-19
Abstract: A biological material comprising two components is provided containing a first component comprising alternatively (1) a culture of autologous or homologous bone marrow stem cells partially or completely differentiated into specific connective tissue cellular lines or (2) a sole extracellular matrix free from any cellular component secreted by the specific connective tissue cellular lines; and a second component containing a three-dimensional biocompatible and biodegradable matrix consisting of a hyaluronic acid ester having a degree of esterification comprised between 25 and 100%. The specific tissue cell lines are selected from fibroblasts, osteoblasts, myoblasts, adipocytes, chondrocytes and endothelial cells. The biological material is suitable for use as a dermal substitute in cutaneous lesions as well as repairing damaged connective tissue.
Patent PT-989999-E (PT)
Inventor: BIZOUARNE NADINE
IPC: C12N7/00
Filed: 1998-07-17
Abstract: Antitumoral compositions can comprise as therapeutic agent one or several immunogenic polypeptides, of which at least one is modified so as to have a cell location different from its native location. Compositions can be based on a recombinant vector expressing such an immunogenic polypeptide. A recombinant vector comprising at least the sequences coding for an immunogenic polypeptide originating from a precocious and/or tardive region of a papillomavirus having a modified location and a viral particle comprising said vector is also described. Finally, therapeutic uses of such a composition, such a recombinant vector and such a viral particle are described.
Patent PT-974580-E (PT)
Inventor: OHUCHIDA SHUICHI
IPC: A61K31/557
Filed: 1999-07-20
Abstract: omega -Cycloalkyl-prostaglandin E1 derivatives of formula (I) <CHEM> wherein R<1> is OH etc.; X is Cl, F; R<2> is H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl which may be substituted; n is 0-4.), non-toxic salts thereof or cyclodextrin clathrates thereof can strongly bind on EP2 subtype receptor. Therefore, they are useful for the prevention and/or treatment of immunological diseases (autoimmune diseases, post-transplantation graft rejection etc.), asthma, abnormal bone formation, neuronal cell death, hepatopathy, abortion, premature birth or retina neuropathy (e.g. glaucoma) etc.
Patent SG-9385-G (SG)
Title: Device for flushing sewers by siphonic action
IPC: E03F7/00
Filed: 1985-02-05
Abstract: A liquid-plug-creating device includes a collection tank or basin into which liquid flows such as the outflow from sanitary appliances. From the outlet at the bottom of the tank a riser extends upwardly at an acute angle to the horizontal. At the opposite end from the tank outlet, the riser terminates in a bend which reverses the direction of flow through the riser into a downwardly extending vertical pipe. A U-shaped piece of pipe with a horizontal outlet is connected to the lower end of the vertical pipe and provides a special form of trap. When the tank and the riser are completely filled with liquid, any additional liquid added exceeding a minimum flow, causes a liquid seal to be formed in the piece of pipe at the lower end of the vertical pipe. The excess flow creates a vacuum in the vertical pipe which sucks the liquid through the riser out of the tank in the manner of a siphon. The liquid immerges from the device in the form of continuous plugs with high kinetic energy content. The device permits the use of small-diameter pipes in house drainage systems while assuring the required self-cleansing effect, even if water-conserving flush toilets are connected to the device. Other fields of application of the device are irrigation and the metering of liquids in batches.
Patent SG-11290-G (SG)
Title: Poly(arylene sulfide)electrical component
IPC: H01G4/06
Filed: 1990-02-16
Abstract: @ A poly(arylene sulfide) capacitor is described comprising upper and lower poly(arylene sulfide) conductive layers and an intermediate poly(arylene sulfide) dielectric. The conductive layers are preferably chemically-doped amorphous poly(phenylene sulfide). A method of preparing such a capacitor from a film of poly(arylene sulfide) is described.
Patent SG-12795-G (SG)
Title: Substituted 4-(quinolin-2-yl-methoxy) phenyl-acetic-acid derivatives
Inventor: MOHRS KLAUS DR
IPC: C07D405/12
Filed: 1995-01-26
Abstract: Substituted 4-(2-quinolinylmethoxy)phenylacetic acid derivatives can be prepared from corresponding 4-(2-quinolinylmethoxy)phenylacetic esters. The compounds can be employed in medicaments.
Patent SG-35394-G (SG)
Title: High barrier packages for smoking articles and other products
Inventor: HEIN III CARL CHRISTIAN
IPC: B65D65/40
Filed: 1994-03-10
Abstract: A high barrier sealable packaging material (10) and a high barrier heat sealed package (80) for smoking articles, such as cigarettes (98) and the like, are disclosed. The packaging material (10) comprises a base layer (12) of a polymeric film, such as a biaxially oriented polyethylene terephthalate (PET) film which has been metallized on one surface thereof with a layer of metal (14), such as aluminium. The metallized film is then imprinted with ink with a design and/or printed matter on either the metallized or unmetallized surface. Subsequently to or concurrently with the printing, a heat seal layer (18,19) is applied to the printed and/or unprinted surface for forming a heat seal about which the material is wrapped. In one embodiment, the high barrier packaging material (10) is used as an overwrap (102) for a cigarette package (80) having a tear tape (108) for removing one end of the overwrap (102). In another embodiment, the high barrier packaging material (10) is used as an overwrap (208) for a carton (200) containing a plurality of cigarette packages (204) and having a tear tape (214) for removing one end of the carton overwrap (208). <IMAGE>
Patent SG-41387-G (SG)
Title: Wire bonding apparatus
IPC: H01L21/60
Filed: 1987-05-06
Abstract: A wire bonding apparatus which can variously change the shape of a loop of a bonding wire and can restrict the loop shape in accordance with specifications of an article being wire bonded. In the wire bonding apparatus, a wire guide unit moving both vertically and transversely, independently of a bonding tool, is disposed in proximity of the bonding tool which moves relative to the article to be wire bonded and which connects the wire between a first bonding region and the second bonding region. A mechanism is provided which changes the shape of the loop of the bonding wire when the wire guide unit moves vertically and transversely.
Patent SG-98287-G (SG)
Title: Blends of cellulase-free xanthan gum and cellulosics
IPC: C08L1/28
Filed: 1987-11-04
Abstract: Cellulase-free xanthan gum is blended with carboxymethyl cellulose, hydroxyethylcellulose or hydroxypropylmethyl cellulose. At 1:1 weight ratio, these blends show surprising viscosities when tested in aqueous solutions of 1%, 0.5%, 0.25% and 0.1% total gum concentration. The blends have utility in any application where cellulosics are used as thickeners, such as industrial or food applications, e.g., toothpaste, or drink mix formulations.
Patent IE-840007-L (IE)
Title: Removable lining for tridimensional article
IPC: D05B25/00
Filed: 1984-01-04
Abstract: This invention relates to a method for manufacturing removable linings to snugly wrap articles having a tridimensional outline. Such a method, which starts from a roll of fabric, of a nonwoven fabric, knitted fabric, meshed fabric and other fabrics, manufactures such linings continuously through a sequence of operations which are carried out in orderly marshalled stations. The finished linings thus obtained has, on the end folds of at least one of two opposite sides, a crease of the same folds sewn in the vicinity of the two nonfolded sides of the fabric piece. An additional and preferred embodiment exhibits corrugation members which can slide within seatings formed by an edging, said edging and said corrugation members being, in their turn, enclosed within the crease of said folds.
[US4642826A]
Patent IE-42243-L (IE)
Title: Diverted conductor driving systems for the drilling of wells
IPC: E21B15/04
Filed: 1976-01-20
Abstract: A method and technique for a deviated (non-vertical) emplacement of a conductor casing at a desired curver and orientation in order to facilitate directional drilling of a well in the substratum of an offshore well site. The method provides for the installation of a relatively short, offset portion of the conductor casing at only the bottom of the conductor pipe string and thereby utilizing this offset portion to force the conductor string in a desired direction and orientation by driving or forcing the conductor casing through a substratum in such a manner that the casing will assume the desired curvature and direction as it advances through the substratum. In addition to the offset or dog-leg segment at the bottom, key-way type guide bars can be added in the longitudinal direction to resist undesired rotation of the conductor pipe.
[US4027734A]
Patent IE-860125-L (IE)
Title: Piperazinyl pyridines
IPC: A61K31/496
Filed: 1986-01-15
Abstract: Disubstituted N,N-piperazinyl derivatives are disclosed wherein one substituent is a substituted pyridin-2-yl ring and the second substituent is a butylene chain attached to cyclic imide heterocycles such as azaspiro[4.5]decanedione, dialkylglutarimide, thiazolidinedione, spirocyclopentylthiazolidinedione, or morpholine-2,6-dione. The compounds have psychotropic properties and 2-[4-[4-(2,4-dioxo-1-thia-3-azaspiro[4.5]nonane-3-yl)butyl]-1-piperazi nyl]pyridine-3-carboxaldehyde is a typical embodiment having selective antipsychotic activity.
[US4619930A]